Raltegravir
DrugBank ID: DB06817
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| HIV infectious disease | 0.9989 | DL |
| feline acquired immunodeficiency syndrome | 0.9978 | DL |
| simian immunodeficiency virus infection | 0.9978 | DL |
| neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 0.9977 | DL |
| AIDS | 0.9839 | DL |
| AIDS related complex | 0.9649 | DL |
| congenital human immunodeficiency virus | 0.9649 | DL |
| obsolete familial combined hyperlipidemia | 0.9598 | DL |
| fibroma of prostate | 0.9444 | DL |
| breast fibrocystic disease | 0.9386 | DL |
| benign reproductive system neoplasm | 0.9372 | DL |
| Brenner tumor | 0.9357 | DL |
| benign prostate phyllodes tumor | 0.9336 | DL |
| apocrine adenosis of breast | 0.9226 | DL |
| blunt duct adenosis of breast | 0.9226 | DL |
| male reproductive organ cancer | 0.9213 | DL |
| prostate cancer/brain cancer susceptibility | 0.9201 | DL |
| benign mammary dysplasia | 0.9182 | DL |
| prostate leiomyoma | 0.9111 | DL |
| breast abscess | 0.8278 | DL |
| fat necrosis of breast | 0.8278 | DL |
| lactation disease | 0.8195 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.8152 | DL |
| hepatoportal sclerosis | 0.8152 | DL |
| hepatopulmonary syndrome | 0.8152 | DL |
| idiopathic copper-associated cirrhosis | 0.8152 | DL |
| primitive portal vein thrombosis | 0.8152 | DL |
| hypercholesterolemia, autosomal dominant | 0.8133 | DL |
| breast adenosis | 0.8091 | DL |
| ulceration of vulva | 0.7853 | DL |
| chronic hepatitis C virus infection | 0.7727 | DL |
| vulvar neoplasm | 0.7685 | DL |
| disorder of tyrosine metabolism | 0.7679 | DL |
| hyperlipoproteinemia | 0.7422 | DL |
| hepatic porphyria | 0.7380 | DL |
| vulvitis | 0.7354 | DL |
| teratogenic Pierre Robin syndrome | 0.7287 | DL |
| disorder of phenylalanine metabolism | 0.7286 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.7185 | DL |
| female breast carcinoma | 0.7114 | DL |
| obsolete functional visual loss | 0.6536 | DL |
| obsolete breast fibroadenosis | 0.6498 | DL |
| guttate psoriasis | 0.6270 | DL |
| prostate neoplasm | 0.6263 | DL |
| cholecystolithiasis | 0.6214 | DL |
| obsolete superimposed infection | 0.6191 | DL |
| ocular tuberculosis | 0.6178 | DL |
| thrombophlebitis | 0.6132 | DL |
| arteriosclerosis obliterans | 0.6095 | DL |
| sunburn | 0.6087 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.